Welcome to the latest weekly update from The Evidence Base®
Explore our daily highlights from all three days of the #ISPEAnnual2024 conference.
Read our interview with Ashita Batavia, MD, MS (Johnson & Johnson Innovative Medicine) to learn more about the FDA grant award project ‘Development of Novel Methods to Enable Robust Comparison of Real-World Progression Free Survival (rwPFS) and Clinical Trial PFS in Multiple Myeloma’.
I share my Editor’s picks from the September issue of the Journal of Comparative Effectiveness Research, including an Editorial on whether there is a need for an international ISPOR—The Professional Society for Health Economics and Outcomes Research value flower and research assessing the #realworldevidence frameworks provided by #regulatory and #HTA agencies.
Check out our Guest Column which explores how researchers can improve patient treatments and outcomes by incorporating #SDOH variables into their work.
Don't forget to sign up to our #webinars, including:
- Introducing the #ROPAD consortium: unlocking real-world genetic insights to accelerate treatment access for Parkinson’s disease, September 24, 10:30am ET (CENTOGENE)
- Incorporating patient centric sampling into multi-center clinical trials: Summary of a PCSIG workshop, October 2, 2024, 11:00AM ET
- Replacing serum with dried blood microsampling for pediatric pharmacokinetics of prophylactic RSV monoclonal antibody, September 25, 2024, 11:00am ET
Plus, #RWE and #RWD news from NICE - National Institute for Health and Care Excellence, OMNY Health and the NHS